VALIDATION OF RESONANT MOLECULAR SIGNALING
Beech Tree Labs and its predecessor, Milkhaus Laboratory, have conducted a number of controlled clinical trials that individually and collectively demonstrate the promise of the RMS approach to therapy. Disorders targeted in the successful trials include:
- Multiple sclerosis
- Benign Prostatic Hyperplasia
- Urinary Incontinence
- Chronic Fatigue Syndrome
- Chronic Obstructive Pulmonary Disease
- Herpesvirus Infection
- Chronic Bronchitis
- Cancer (FDA and USDA)
- Myositis (USDA)
- Cardiomyopathy
Validation of this approach is also found in the publication of peer-reviewed papers addressing the mechanism of action and clinical efficacy of Beech Tree’s therapeutic agents.
Visit our Publications page to learn more.